Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review

In the present study, we aimed to report our experience with rituximab (RTX) in the treatment of patients with ILD associated with AD (AD-ILD) at a single center. For this purpose, clinical characteristics, radiological findings, and pulmonary function tests (PFTs) of RTX-treated AD-ILD-patients see...

Full description

Bibliographic Details
Main Authors: Belén Atienza-Mateo, Sara Remuzgo-Martínez, Diana Prieto-Peña, Víctor Manuel Mora Cuesta, David Iturbe-Fernández, Javier Llorca, Lara Sánchez-Bilbao, Alfonso Corrales, Gerardo Blanco Blanco Rodríguez, José Javier Gómez-Román, José Manuel Cifrián, Miguel Ángel González-Gay
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
autoimmune diseases
interstitial lung disease
rituximab
review
Online Access:https://www.mdpi.com/2077-0383/9/10/3070

Internet

https://www.mdpi.com/2077-0383/9/10/3070

Similar Items